Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)

CUSIP: 50127T109

Q2 2018 13F Holders as of 30 Jun 2018

Holder snapshot 7 signals
Share change
+6,197,910
Put/Call ratio
1147%
SEC-reported price per share
$18.20
Number of holders
108
Value change
+$112,569,821
Number of buys
63
Open additional details 1 more signal available
Number of sells
41
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
88,321,513

Security key

50127T109

Report period

Q2 2018

Institutions

108

Top holders

10

Ownership snapshot

Top reported holders of KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Mar 2018
13F Lead comparable stake: 5% Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 5%
EcoR1 Capital, LLC 4.3%
GREAT POINT PARTNERS LLC 2.7%
BlackRock Finance, Inc. 1.8%
BVF INC/IL 1.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
5%
$83,128,000
4,433,515 shares
31 Mar 2018
EcoR1 Capital, LLC
13F
Company
13F
4.3%
$70,628,000
3,766,852 shares
31 Mar 2018
GREAT POINT PARTNERS LLC
13F
Company
13F
2.7%
$44,641,000
2,380,846 shares
31 Mar 2018
BlackRock Finance, Inc.
13F
Company
13F
1.8%
$29,910,000
1,595,302 shares
31 Mar 2018
BVF INC/IL
13F
Company
13F
1.5%
$25,385,000
1,353,846 shares
31 Mar 2018
PFM Health Sciences, LP
13F
Company
13F
1.5%
$25,113,000
1,339,362 shares
31 Mar 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
108
Shares
29,714,074
Rows available
108
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders
98
Q2 2018 holders
108
Holder diff
10
Investor Q1 2018 Shares Q2 2018 Shares Share Diff Share Chg % Q1 2018 value Q2 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .